Carmel Murone
Impact in
- Oncology top 5%
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
Papers in
- Oncology 21
- Colorectal Cancer Treatments and Studies 7
- HER2/EGFR in Cancer Research 5
- Cancer Immunotherapy and Biomarkers 5
-
- Cancer, Hypoxia, and Metabolism 5
- Co-authors
- Andrew M. ScottNiall C. TebbuttLloyd J. OldTerrance G. JohnsTimothy PriceAntony W. BurgessRodney B. LuworAnthony T. Papenfuss
- Journals
- Journal of Clinical Oncology (10 papers)Clinical Cancer Research (3 papers)PLoS ONE (3 papers)Scientific Reports (2 papers)Journal of Thoracic Oncology (2 papers)
- Partner nations
- AustraliaUnited StatesBelgium
In The Last Decade
Carmel Murone
51 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 84
- Oncology 780
- Cancer Research 371
- Radiology, Nuclear Medicine and Imaging 500
- Genetics 222
- Pulmonary and Respiratory Medicine 511
Countries citing papers authored by Carmel Murone
This map shows the geographic impact of Carmel Murone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmel Murone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmel Murone more than expected).
Fields of papers citing papers by Carmel Murone
This network shows the impact of papers produced by Carmel Murone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmel Murone. The network helps show where Carmel Murone may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Carmel Murone, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2020 | 11 | |
| 4 | 2020 | 10 | |
| 5 | 2019 | 6 | |
| 6 | 2018 | 12 | |
| 7 | 2018 | 1 | |
| 8 | 2017 | 73 | |
| 9 | 2016 | 15 | |
| 10 | 2016 | 67 | |
| 11 | 2016 | 5 | |
| 12 | 2014 | 67 | |
| 13 | 2014 | 18 | |
| 14 | 2014 | 9 | |
| 15 | 2014 | 38 | |
| 16 | 2013 | 3 | |
| 17 | 2012 | 26 | |
| 18 | 2005 | 84 | |
| 19 | 1997 | 45 | |
| 20 | 1996 | 7 |
About Carmel Murone
Carmel Murone is a scholar working on Oncology, Cancer Research, Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Hepatology, having authored 51 papers that have together received 1.8k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (10 papers), Colorectal Cancer Treatments and Studies (7 papers), Occupational and environmental lung diseases (6 papers), Lung Cancer Treatments and Mutations (6 papers), Radiopharmaceutical Chemistry and Applications (5 papers), HER2/EGFR in Cancer Research (5 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Cancer Immunotherapy and Biomarkers (5 papers). The work is most often cited by research in Oncology (780 citations), Cancer Research (371 citations), Radiology, Nuclear Medicine and Imaging (500 citations), Genetics (222 citations) and Pulmonary and Respiratory Medicine (511 citations). Carmel Murone has collaborated with scholars based in Australia, United States and Belgium. Frequent co-authors include Andrew M. Scott, Niall C. Tebbutt, Lloyd J. Old, Terrance G. Johns, Timothy Price, Antony W. Burgess, Rodney B. Luwor, Anthony T. Papenfuss, Simon Knight and Graeme O’Keefe. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, PLoS ONE, Scientific Reports and Journal of Thoracic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.